Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis.
Ramonda R, Lorenzin M, Chimenti MS, D'Angelo S, Marchesoni A, Selmi C, Lubrano E, Santo L, Luchetti Gentiloni MM, Atzeni F, Cauli A, Manara M, Rossini M, Foti R, Cozzi G, Scagnellato L, Ferraioli M, Carriero A, Luciano N, Ruzzon F, Fatica M, Fracassi E, Doria A, Foti R, Carletto A.
Ramonda R, et al. Among authors: carriero a.
Front Immunol. 2024 Jul 15;15:1435599. doi: 10.3389/fimmu.2024.1435599. eCollection 2024.
Front Immunol. 2024.
PMID: 39076975
Free PMC article.